Sign in
4

Changes in Ownership

Lexaria Bioscience Corp. Filed Acc 0001103780-20-000004

CEO bought 195,500 shares at an average $0.20 ($39,769)

From the SEC's structured data for this filing

Trades in this filing

BUNKA CHRISTOPHER · CEO

Table I: Non-derivative

10 lines
Date Transaction Shares Price Value Owned after D/I
2020-11-06 Purchase : show line 1 in the form +60,000 $0.21 $12,306 6,341,844 I
2020-11-09 Purchase : show line 2 in the form +37,500 $0.22 $8,063 6,379,344 I
2020-11-09 Purchase : show line 3 in the form +10,000 $0.20 $2,025 6,389,344 I
2020-11-09 Purchase : show line 4 in the form +10,000 $0.21 $2,129 6,399,344 I
2020-11-09 Purchase : show line 5 in the form +8,000 $0.20 $1,600 6,407,344 I
2020-11-09 Purchase : show line 6 in the form +6,500 $0.20 $1,307 6,413,844 I
2020-11-09 Purchase : show line 7 in the form +22,000 $0.20 $4,391 6,435,844 I
2020-11-10 Purchase : show line 8 in the form +10,000 $0.20 $1,950 6,445,844 I
2020-11-10 Purchase : show line 9 in the form +6,000 $0.20 $1,199 6,451,844 I
2020-11-10 Purchase : show line 10 in the form +25,500 $0.19 $4,799 6,477,344 I
Open-market purchases · 195,500 sh · avg $0.20 · $39,769
Loading xslF345X03/primary_doc.xml…